Larry Cai

Larry Cai 蔡凌希 is an accomplished business leader with extensive experience in the pharmaceutical industry. Currently serving as a Board Member for the Sino-American Pharmaceutical Professionals Association (SAPA) and Chief Business Officer at Defand Therapeutics, Larry has a strong background in strategic business development and international partnerships. With roles including President and Advisory Committee Member at SAPA-New England/Boston, Founder of LLC Consulting Corp., and various executive positions at companies such as Axter Therapeutics, Fosun Pharma USA, and Guangzhou Boji Biomedical, Larry has consistently demonstrated leadership in business growth and alliances. Larry holds an MBA from Babson F.W. Olin Graduate School of Business and advanced degrees in Chemistry from The Ohio State University and the University of Mississippi, along with coursework at Peking University.